These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27846975)

  • 1. Segmental stiff skin syndrome (SSS): Two additional cases with a positive response to mycophenolate mofetil and physical therapy.
    Kurtzman DJ; Wright NA; Patel M; Vleugels RA
    J Am Acad Dermatol; 2016 Dec; 75(6):e237-e239. PubMed ID: 27846975
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of segmental stiff skin syndrome treated with systemic losartan.
    Maillet-Lebel N; Kokta V; Coulombe J; Powell J
    Pediatr Dermatol; 2018 Jan; 35(1):e66-e67. PubMed ID: 29110325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification and rising medication therapy in stiff skin syndrome: A case report and literature review.
    Lin Z; Pei Y; Tang X; Rong L; Chen L; Jiang X
    Dermatol Ther; 2022 Aug; 35(8):e15633. PubMed ID: 35686816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segmental stiff skin syndrome treated with secukinumab.
    Gelinas A; Powell J; Lapointe C; Coulombe J
    Pediatr Dermatol; 2023; 40(4):738-739. PubMed ID: 36825671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmental stiff skin syndrome: a novel case with an interleukin-17C mutation successfully treated with secukinumab.
    Rangu S; Rubin AI; Li D; Castelo-Soccio L
    Clin Exp Dermatol; 2020 Jul; 45(5):658-660. PubMed ID: 32212274
    [No Abstract]   [Full Text] [Related]  

  • 6. Churg-Strauss syndrome: successful treatment with mycophenolate mofetil.
    Assaf C; Mewis G; Orfanos CE; Geilen CC
    Br J Dermatol; 2004 Mar; 150(3):598-600. PubMed ID: 15030353
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil.
    Goyal S; Nousari HC
    J Am Acad Dermatol; 2001 Jul; 45(1):142-4. PubMed ID: 11423853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil.
    Heymann WR
    J Am Acad Dermatol; 2005 Dec; 53(6):1045-6. PubMed ID: 16310066
    [No Abstract]   [Full Text] [Related]  

  • 9. Segmental stiff skin syndrome (SSS): A distinct clinical entity.
    Myers KL; Mir A; Schaffer JV; Meehan SA; Orlow SJ; Brinster NK
    J Am Acad Dermatol; 2016 Jul; 75(1):163-8. PubMed ID: 26944597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil in primary glomerulopathies.
    Sepe V; Libetta C; Giuliano MG; Adamo G; Dal Canton A
    Kidney Int; 2008 Jan; 73(2):154-62. PubMed ID: 17989649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil: new applications for this immunosuppressant.
    Moder KG
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
    Wang A; Smith JR; Creevy KE
    J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolic acid in dermatology a century after its discovery.
    Strathie Page SJ; Tait CP
    Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.
    Talhari C; Mahnke N; Ruzicka T; Megahed M
    Clin Exp Dermatol; 2005 May; 30(3):297-8. PubMed ID: 15807696
    [No Abstract]   [Full Text] [Related]  

  • 17. Rescue therapy with mycophenolate mofetil in refractory uveitis.
    Kilmartin DJ; Forrester JV; Dick AD
    Lancet; 1998 Jul; 352(9121):35-6. PubMed ID: 9800750
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil].
    Noroña B; Valentín M; Gutiérrez E; Praga M
    Nefrologia; 2004; 24(1):79-82. PubMed ID: 15083963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.